Scientific References
1. Cogn Brain Res. 2002 May;13(3):407-15. Maximum cognitive performance and physiological time trend measurements after caffeine intake. Kourtidou-Papadeli C, Papadelis C, Louizos AL, Guiba-Tziampiri O.
2. Diabetes. 2002 Mar;51(3):583-90. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Thong FS, Derave W, Kiens B, Graham TE, Urso B, Wojtaszewski JF, Hansen BF, Richter EA.
3. Am J Physiol Regul Integr Comp Physiol. 2003 Feb;284(2):R399-404. Epub 2002 Oct 24. Central nervous system effects of caffeine and adenosine on fatigue. Davis JM, Zhao Z, Stock HS, Mehl KA, Buggy J, Hand GA.
4. J Appl Physiol. 2002 Oct;93(4):1227-34. Exercise endurance 1, 3, and 6 h after caffeine ingestion in caffeine users and nonusers. Bell DG, McLellan TM.
5. Brain Cogn. 2003 Feb;51(1):143-54. Effects of mental workload and caffeine on catecholamines and blood pressure compared to performance variations. Papadelis C, Kourtidou-Papadeli C, Vlachogiannis E, Skepastianos P, Bamidis P, Maglaveras N, Pappas K.
6. J Appl Physiol. 2002 Sep;93(3):990-9. Effect of different protocols of caffeine intake on metabolism and endurance performance. Cox GR, Desbrow B, Montgomery PG, Anderson ME, Bruce CR, Macrides TA, Martin DT, Moquin A, Roberts A, Hawley JA, Burke LM.
7. Neurosci Lett. 2001 Jul 27;308(1):25-8. Caffeine inhibits exercise-induced increase in tryptophan hydroxylase expression in dorsal and median raphe of Sprague-Dawley rats. Lim BV, Jang MH, Shin MC, Kim HB, Kim YJ, Kim YP, Chung JH, Kim H, Shin MS, Kim SS, Kim EH, Kim CJ.
8. Aviat Space Environ Med. 1998 Dec;69(12):1178-81. Thermoregulatory effects of caffeine ingestion during submaximal exercise in men. Dunagan N, Greenleaf JE, Cisar CJ.
9. J Appl Physiol. 1998 Aug;85(2):709-15. Effect of caffeinated drinks on substrate metabolism, caffeine excretion, and performance. Kovacs EM, Stegen JHCH, Brouns F.
10. Med Sci Sports Exerc. 2002 Nov;34(11):1785-92. Caffeine is ergogenic after supplementation of oral creatine monohydrate. Doherty M, Smith PM, Davison RC, Hughes MG.Pediatrics. 2003 Jan;111(1):42-6. Caffeine consumption and weekly sleep patterns in US seventh-, eighth-, and ninth-graders. Pollak CP, Bright D.
11. J Appl Physiol. 2002 Feb;92(2):513-8. Opposite actions of caffeine and creatine on muscle relaxation time in humans. Hespel P, Op't Eijnde B, Van Leemputte M.
12. J Nutr Sci Vitaminol (Tokyo). 2001 Dec;47(6):378-84. Effects of carnitine coingested caffeine on carnitine metabolism and endurance capacity in athletes. Cha YS, Choi SK, Suh H, Lee SN, Cho D, Li K.
13. JAMA 2003 Mar 26;289(12):1537-45. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagne J.
14. J Appl Physiol. 2001 Oct;91(4):1535-44. Caffeine increases endurance and attenuates force sensation during submaximal isometric contractions. Plaskett CJ, Cafarelli E.
15. J Appl Physiol. 2000 Nov;89(5):1719-24. Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitual caffeine consumers. Tarnopolsky M, Cupido C.
16. Jpn J Physiol. 2001 Dec;51(6):761-4. Caffeine ingestion attenuates the VO(2) slow component during intense exercise. Santalla A, Lucia A, Perez M.
17. Psychopharmacology (Berl). 2002 Dec;164(4):429-31. Epub 2002 Oct 24. The moderating effect of anxiety sensitivity on caffeine-induced hypoalgesia in healthy women. Keogh E, Chaloner N.
18. Am J Clin Nutr. 2003 Jun;77(6):1442-7. Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men. Jessen AB, Toubro S, Astrup A.
19. Clin Exp Pharmacol Physiol. 2002 May-Jun;29(5-6):391-4. Effects of caffeine on the uncoupling protein family in obese yellow KK mice. Kogure A, Sakane N, Takakura Y, Umekawa T, Yoshioka K, Nishino H, Yamamoto T, Kawada T, Yoshikawa T, Yoshida T.
20. Br J Nutr. 2001 Feb;85(2):203-11. Combined effects of red pepper and caffeine consumption on 24 h energy balance in subjects given free access to foods. Yoshioka M, Doucet E, Drapeau V, Dionne I, Tremblay A.
21. Dermatol Surg. 1999 Jun;25(6):455-62. Modification of subcutaneous adipose tissue by a methylxanthine formulation: a double-blind controlled study. Lesser T, Ritvo E, Moy LS.
22. Phytomedicine. 2002 Jan;9(1):3-8. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Chantre P, Lairon D.
23. J Nutr. 2000 Feb;130(2):152-7. Caffeine, carnitine and choline supplementation of rats decreases body fat and serum leptin concentration as does exercise. Hongu N, Sachan DS.
24. Psychopharmacology (Berl). 2003 Jan;165(3):280-90. Epub 2002 Nov 14. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers. Jones HE, Griffiths RR.
25. Food Chem Toxicol. 2002 Sep;40(9):1243-55. Effects of caffeine on human behavior. Smith A.
26. Br J Clin Pharmacol. 2002 Oct;54(4):400-6. Central and peripheral effects of sustained caffeine use: tolerance is incomplete. Watson J, Deary I, Kerr D.
27. Hum Psychopharmacol. 2002 Oct;17(7):361-7. Evidence for a relationship between daily caffeine consumption and accuracy of time estimation. Stine MM, O'Connor RJ, Yatko BR, Grunberg NE, Klein LC.
28. Int J Sports Med. 1999 Aug;20(6):354-61. Caffeine improves cognitive performance after strenuous physical exercise. Hogervorst E, Riedel WJ, Kovacs E, Brouns F, Jolles J.
29. J Sleep Res. 2001 Dec;10(4):265-76. Slow release caffeine and prolonged (64-h) continuous wakefulness: effects on vigilance and cognitive performance. Beaumont M, Batejat D, Pierard C, Coste O, Doireau P, Van Beers P, Chauffard F, Chassard D, Enslen M, Denis JB, Lagarde D.
30. Psychopharmacology (Berl). 2002 Jan;159(3):238-47. Epub 2001 Oct 19. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ.
31. Aviat Space Environ Med. 2003 Apr;74(4):309-14. Caffeine effects on marksmanship during high-stress military training with 72 hour sleep deprivation. Tharion WJ, Shukitt-Hale B, Lieberman HR.
32. Am J Epidemiol. 2002 Nov 1;156(9):842-50. Coffee consumption and cognitive function among older adults. Johnson-Kozlow M, Kritz-Silverstein D, Barrett-Connor E, Morton D.
33. Psychopharmacology (Berl). 2003 Apr;167(1):54-62. Epub 2003 Feb 25. Absence of reinforcing, mood and psychomotor performance effects of caffeine in habitual non-consumers of caffeine. Rogers PJ, Martin J, Smith C, Heatherley SV, Smit HJ.
34. Food Chem Toxicol. 2002 Sep;40(9):1257-61. Caffeine: behavioral effects of withdrawal and related issues. Dews PB, O'Brien CP, Bergman J.
35. Cochrane Database Syst Rev. 2001;(4):CD001112. Caffeine for asthma. Bara AI, Barley EA.
36. Curr Pain Headache Rep. 2001 Oct;5(5):472-8. The use of ibuprofen plus caffeine to treat tension-type headache. Diamond S, Freitag FG.
37. Eur J Appl Physiol. 2001 Jul;85(1-2):144-50. Resynchronization of hormonal rhythms after an eastbound flight in humans: effects of slow-release caffeine and melatonin. Pierard C, Beaumont M, Enslen M, Chauffard F, Tan DX, Reiter RJ, Fontan A, French J, Coste O, Lagarde D.
38. Clin Chim Acta. 2000 May;295(1-2):141-54. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Lee C.
39. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12455-60. Epub 2002 Aug 30. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Lu YP, Lou YR, Xie JG, Peng QY, Liao J, Yang CS, Huang MT, Conney AH.
40. Cancer Res. 2001 Jul 1;61(13):5002-9. Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Lu YP, Lou YR, Lin Y, Shih WJ, Huang MT, Yang CS, Conney AH.
41. Indian J Exp Biol. 2001 Dec;39(12):1254-7. Radioprotective action of caffeine: use of Saccharomyces cerevisiae as a test system. Vaidya PJ, Pasupathy K.
42. Cancer Lett. 2003 May 8;194(1):25-35. Mechanistic approach of contrasting modifying effects of caffeine on carcinogenesis in the rat colon and mammary gland induced with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Takeshita F, Ogawa K, Asamoto M, Shirai T.
43. J Exp Clin Cancer Res. 2001 Jun;20(2):287-92. Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. Gude RP, Menon LG, Rao SG.
44. Stroke. 2003 May;34(5):1242-5. Epub 2003 Apr 10. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke. Piriyawat P, Labiche LA, Burgin WS, Aronowski JA, Grotta JC.
45. Eur J Neurol. 2002 Jul;9(4):377-82. Does caffeine intake protect from Alzheimer's disease? Maia L, de Mendonca A.
46. Ann Neurol. 2001 Jul;50(1):56-63. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC.
47. Int J Sport Nutr Exerc Metab. 2002 Jun;12(2):189-206. Caffeine, body fluid-electrolyte balance, and exercise performance. Armstrong LE.
48. Am J Clin Nutr. 2002 Dec;76(6):1244-8. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Verhoef P, Pasman WJ, Van Vliet T, Urgert R, Katan MB.
49. J Appl Physiol. 2002 Jun;92(6):2347-52. Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. Thong FS, Graham TE.
50. Neuropsychopharmacology. 2003 Sep;28(9):1694-702. Epub 2003 Jun 25. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Alsene K, Deckert J, Sand P, de Wit H.
51. Hum Psychopharmacol. 2002 Apr;17(3):151-6. Interactions between alcohol and caffeine in relation to psychomotor speed and accuracy. Mackay M, Tiplady B, Scholey AB.
52. Psychopharmacology (Berl). 2002 Jul;162(3):246-54. Epub 2002 May 14. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists. Cauli O, Morelli M.
53. Clin Pharmacol Ther. 2002 Mar;71(3):141-52. Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19). Christensen M, Tybring G, Mihara K, Yasui-Furokori N, Carrillo JA, Ramos SI, Andersson K, Dahl ML, Bertilsson L.
54. Clin Pharmacokinet. 2000 Aug;39(2):127-53. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Carrillo JA, Benitez J.
55. J Pharmacol Exp Ther. 2003 Jul;306(1):35-42. Epub 2003 Mar 27. Toxicity of acetaminophen, salicylic acid, and caffeine for first-passage rat renal inner medullary collecting duct cells. Cai Q, Dmitrieva NI, Michea LF, Rocha G, Ferguson D, Burg MB.
56. Toxicol Appl Pharmacol. 2002 Dec 1;185(2):91-7. Effect of caffeine on acetaminophen hepatotoxicity in cultured hepatocytes treated with ethanol and isopentanol. DiPetrillo K, Wood S, Kostrubsky V, Chatfield K, Bement J, Wrighton S, Jeffery E, Sinclair P, Sinclair J.
57. J Am Coll Nutr. 2002 Dec;21(6):536-44. To drink or not to drink: how are alcohol, caffeine and past smoking related to bone mineral density in elderly women? Ilich JZ, Brownbill RA, Tamborini L, Crncevic-Orlic Z.
58. Song DK, Suh HW, Jung JS, Wie MB, Son KH, Kim YH. Antidepressant-like effects of p-synephrine in mouse models of immobility tests. Neurosci Lett. 1996 Aug 23;214(2-3):107-10. [abstract]
59. Brown CM, McGrath JC, Midgley JM, Muir AG, O'Brien JW, Thonoor CM, Williams CM, Wilson VG. Activities of octopamine and synephrine stereoisomers on alpha-adrenoceptors. Br J Pharmacol. 1988 Feb;93(2):417-29. [abstract]
60. Flechtner-Mors M, Jenkinson CP, Alt A, Adler G, Ditschuneit HH. In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects. J Pharmacol Exp Ther. 2002 Apr;301(1):229-33. [abstract]
61. Boschmann M, Krupp G, Luft FC, Klaus S, Jordan J. In vivo response to alpha(1)-adrenoreceptor stimulation in human white adipose tissue. Obes Res. 2002 Jun;10(6):555-8. [abstract]
62. Zhao J, Cannon B, Nedergaard J. alpha1-Adrenergic stimulation potentiates the thermogenic action of beta3-adrenoreceptor-generated cAMP in brown fat cells. J Biol Chem. 1997 Dec 26;272(52):32847-56. [Abstract]
63. Schimmel RJ, Elliott ME, Dehmel VC. Interactions between adenosine and alpha 1-adrenergic agonists in regulation of respiration in hamster brown adipocytes. Mol Pharmacol. 1987 Jul;32(1):26-33. [abstract]
64. Raasmaja A, Larsen PR. Alpha 1- and beta-adrenergic agents cause synergistic stimulation of the iodothyronine deiodinase in rat brown adipocytes. Endocrinology. 1989 Nov;125(5):2502-9. [abstract]
65. Cheng JT, Kuo DY. Both alpha1-adrenergic and D(1)-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice. Neurosci Lett. 2003 Aug 21;347(2):136-8. [abstract]